Share on twitter
Share on LinkedIn
Share on Facebook
Email to a friend
Print page
On 24 April the Medicines and Healthcare Products Regulatory Agency (MHRA) changed its regulatory position on medicines containing sodium valproate. MHRA advises that if a woman of childbearing age is to be prescribed sodium valproate, she must be enrolled in a pregnancy prevention programme (PPP). This FSRH statement outlines the implications for daily practice.
Comment submitted by FSRH along with open letter to Secretary of State for Health Jeremy Hunt regarding the NHS Charges to Overseas Visitors Amendment Regulations 2017
Read and download the full response to the Independent Inquiry into Child Sexual Abuse.
FSRH Statement expressing concern for women's health and opportunities following the reinstatement of the Mexico City Policy
Today (24.10.2016) the Academy of Medical Royal Colleges is launching its Choosing Wisely campaign and website, with a list of forty treatments and procedures that are of little or no benefit to patients.
FSRH Submission to Government's consultation on reporting child abuse and neglect
FSRH welcomes the opportunity to respond to the Fair Funding Review.
FSRH welcomes the opportunity to respond to this consultation on proposed 100% Business Rate Retention.
FSRH response to Public Health England’s Tailored Review June 2016
FSRH response to the Heath Select Committee’s Inquiry into Maternity Services and the National Maternity Review’s report Better Births: Improving outcomes of maternity services in England
